Stock Track | Irhythm Technologies Soars 5.3% on Robust Financials and Growth Prospects

Stock Track

Jan 14, 2025

Irhythm Technologies Inc. (IRTC) witnessed a 5.3% surge in its stock price during Tuesday's intraday trading session, fueled by strong financial performance and positive growth prospects.

Analysts at Canaccord Genuity, Needham, and Wells Fargo maintained their buy ratings on IRTC, citing the company's solid revenue performance and strategic expansions. Needham raised its price target to $112, representing a potential upside of 14.8%, driven by the success of Irhythm's heart monitoring devices, Zio monitor and Zio AT.

Additionally, Irhythm Technologies announced preliminary Q4 highlights, indicating that its revenue exceeded guidance expectations. The company achieved record account openings and secured FDA clearance for Zio device advancements. Irhythm also initiated manufacturing automation and plans to enhance its quality systems, further penetrate domestic and international markets, and create sustainable value for stakeholders.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1123858668"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1123858668\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1123858668?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-14 22:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1123858668","market":"us","top_or_hot":-1,"title":"Stock Track | Irhythm Technologies Soars 5.3% on Robust Financials and Growth Prospects","media":"Stock Track","content":"<p>Irhythm Technologies Inc. (IRTC) witnessed a 5.3% surge in its stock price during Tuesday's intraday trading session, fueled by strong financial performance and positive growth prospects.</p>\n\n<p>Analysts at Canaccord Genuity, Needham, and Wells Fargo maintained their buy ratings on IRTC, citing the company's solid revenue performance and strategic expansions. Needham raised its price target to $112, representing a potential upside of 14.8%, driven by the success of Irhythm's heart monitoring devices, Zio monitor and Zio AT.</p>\n\n<p>Additionally, Irhythm Technologies announced preliminary Q4 highlights, indicating that its revenue exceeded guidance expectations. The company achieved record account openings and secured FDA clearance for Zio device advancements. Irhythm also initiated manufacturing automation and plans to enhance its quality systems, further penetrate domestic and international markets, and create sustainable value for stakeholders.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Irhythm Technologies Soars 5.3% on Robust Financials and Growth Prospects</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Irhythm Technologies Soars 5.3% on Robust Financials and Growth Prospects\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-01-14 22:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Irhythm Technologies Inc. (IRTC) witnessed a 5.3% surge in its stock price during Tuesday's intraday trading session, fueled by strong financial performance and positive growth prospects.</p>\n\n<p>Analysts at Canaccord Genuity, Needham, and Wells Fargo maintained their buy ratings on IRTC, citing the company's solid revenue performance and strategic expansions. Needham raised its price target to $112, representing a potential upside of 14.8%, driven by the success of Irhythm's heart monitoring devices, Zio monitor and Zio AT.</p>\n\n<p>Additionally, Irhythm Technologies announced preliminary Q4 highlights, indicating that its revenue exceeded guidance expectations. The company achieved record account openings and secured FDA clearance for Zio device advancements. Irhythm also initiated manufacturing automation and plans to enhance its quality systems, further penetrate domestic and international markets, and create sustainable value for stakeholders.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IRTC","symbol_name":"Irhythm Technologies Inc.","start_time":0,"source_url":"","article_id":"1123858668","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1123858668","pubTimestamp":1736865386,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Irhythm Technologies Inc.  witnessed a 5.3% surge in its stock price during Tuesday's intraday trading session, fueled by strong financial performance and positive growth prospects.Analysts at Canaccord Genuity, Needham, and Wells Fargo maintained their buy ratings on IRTC, citing the company's solid revenue performance and strategic expansions. Needham raised its price target to $112, representing a potential upside of 14.8%, driven by the success of Irhythm's heart monitoring devices, Zio moni","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IRTC":"Irhythm Technologies Inc."},"translate_title":"股票赛道Irhythm Technologies因强劲的财务状况和增长前景而飙升5.3%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IRTC":1},"content_text":"Irhythm Technologies Inc. (IRTC) witnessed a 5.3% surge in its stock price during Tuesday's intraday trading session, fueled by strong financial performance and positive growth prospects.\nAnalysts at Canaccord Genuity, Needham, and Wells Fargo maintained their buy ratings on IRTC, citing the company's solid revenue performance and strategic expansions. Needham raised its price target to $112, representing a potential upside of 14.8%, driven by the success of Irhythm's heart monitoring devices, Zio monitor and Zio AT.\nAdditionally, Irhythm Technologies announced preliminary Q4 highlights, indicating that its revenue exceeded guidance expectations. The company achieved record account openings and secured FDA clearance for Zio device advancements. Irhythm also initiated manufacturing automation and plans to enhance its quality systems, further penetrate domestic and international markets, and create sustainable value for stakeholders.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}